GTCM
IONS icon

Gyon Technologies Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Gyon Technologies Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,376
Closed -$1.01M – 425
2021
Q1 		$1.01M Buy
22,376
+8,760
+64% +$489K 0.44% 48
2020
Q4 		$770K Buy
13,616
+7,965
+141% +$397K 0.26% 118
2020
Q3 		$268K Buy
+5,651
New +$314K 0.21% 173

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Gyon Technologies Capital Management's IONS Position: Q2 2021 in Review

Gyon Technologies Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 22,376 shares — an estimated $1.01M sold.

Gyon Technologies Capital Management first reported a position in IONS in Q3 2020 and held it in 3 quarters. The position peaked at $1.01M in Q1 2021. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Gyon Technologies Capital Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 22,376 Ionis Pharmaceuticals shares in Q2 2021, an estimated $1.01M.
  • Gyon Technologies Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Gyon Technologies Capital Management's Ionis Pharmaceuticals position peaked at $1.01M in Q1 2021.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.